These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38279109)

  • 1. Dapagliflozin in peritoneal dialysis patients: a pilot study evaluating peritoneal membrane function.
    Hamdan Z; Abdel-Hafez Y; Enaya A; Sarsour A; Kharraz L; Nazzal Z
    BMC Nephrol; 2024 Jan; 25(1):37. PubMed ID: 38279109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SGLT2 Inhibition by Intraperitoneal Dapagliflozin Mitigates Peritoneal Fibrosis and Ultrafiltration Failure in a Mouse Model of Chronic Peritoneal Exposure to High-Glucose Dialysate.
    Balzer MS; Rong S; Nordlohne J; Zemtsovski JD; Schmidt S; Stapel B; Bartosova M; von Vietinghoff S; Haller H; Schmitt CP; Shushakova N
    Biomolecules; 2020 Nov; 10(11):. PubMed ID: 33228017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in water transport across the peritoneum during treatment with continuous ambulatory peritoneal dialysis in selected patients with and without peritonitis.
    Radtke M; Albrektsen GE; Widerøe TE; Nilsen TI; Romundstad P; Hallan S; Aasarød K; Laegreid IK; Oien C
    Perit Dial Int; 2004; 24(6):571-9. PubMed ID: 15559487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SGLT-2 inhibitors reduce glucose absorption from peritoneal dialysis solution by suppressing the activity of SGLT-2.
    Zhou Y; Fan J; Zheng C; Yin P; Wu H; Li X; Luo N; Yu X; Chen C
    Biomed Pharmacother; 2019 Jan; 109():1327-1338. PubMed ID: 30551383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of sodium-glucose co-transporter 2 inhibitors on ultrafiltration in patients with peritoneal dialysis: a protocol for a randomized, double-blind, placebo-controlled, crossover trial (EMPOWERED).
    Doi Y; Shinzawa M; Arisato T; Oka H; Matsumoto A; Kitamura H; Nakazono Y; Nishiya Y; Ueda Y; Kamimura T; Hayashi T; Yoshihara F; Isaka Y
    Clin Exp Nephrol; 2024 Jul; 28(7):629-635. PubMed ID: 38402502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between ultrafiltrate volume with icodextrin and peritoneal transport pattern according to the peritoneal equilibration test.
    Araújo Teixeira MR; Pecoits-Filho RF; Romão Junior JE; Sabbaga E; Marcondes MM; Abensur H
    Perit Dial Int; 2002; 22(2):229-33. PubMed ID: 11990408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ISPD recommendations for the evaluation of peritoneal membrane dysfunction in adults: Classification, measurement, interpretation and rationale for intervention.
    Morelle J; Stachowska-Pietka J; Öberg C; Gadola L; La Milia V; Yu Z; Lambie M; Mehrotra R; de Arteaga J; Davies S
    Perit Dial Int; 2021 Jul; 41(4):352-372. PubMed ID: 33563110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Advances on pathogenesis of acquired peritoneal ultrafiltration failure in peritoneal dialysis].
    Jiang N; Xie WZ; Gu LY; Ni ZH; Fang W; Yuan JZ
    Zhonghua Gan Zang Bing Za Zhi; 2023 Jan; 39(1):42-47. PubMed ID: 36776015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peritoneal transport characteristics with glycerol-based dialysate in peritoneal dialysis.
    Smit W; de Waart DR; Struijk DG; Krediet RT
    Perit Dial Int; 2000; 20(5):557-65. PubMed ID: 11117247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A New Method to Increase Ultrafiltration in Peritoneal Dialysis: Steady Concentration Peritoneal Dialysis.
    Pérez-Díaz V; Pérez-Escudero A; Sanz-Ballesteros S; Rodríguez-Portela G; Valenciano-Martínez S; Palomo-Aparicio S; Hernández-García E; Sánchez-García L; Gordillo-Martín R; Marcos-Sánchez H
    Perit Dial Int; 2016 9-10; 36(5):555-61. PubMed ID: 27282854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Model To Estimate Glucose Absorption in Peritoneal Dialysis: A Pilot Study.
    Kotla SK; Saxena A; Saxena R
    Kidney360; 2020 Dec; 1(12):1373-1379. PubMed ID: 35372892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peritoneal fluid transport in CAPD patients with different transport rates of small solutes.
    Sobiecka D; Waniewski J; Weryński A; Lindholm B
    Perit Dial Int; 2004; 24(3):240-51. PubMed ID: 15185772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biocompatible dialysis fluids for peritoneal dialysis.
    Htay H; Johnson DW; Wiggins KJ; Badve SV; Craig JC; Strippoli GF; Cho Y
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD007554. PubMed ID: 30362116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peritoneal function and assessment of reference values using a 3.86% glucose solution.
    Smit W; van Dijk P; Langedijk MJ; Schouten N; van den Berg N; Struijk DG; Krediet RT
    Perit Dial Int; 2003; 23(5):440-9. PubMed ID: 14604195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SGLT-2 inhibitors may increase ultrafiltration in incident peritoneal dialysis patients: a case report.
    Lai JW; Lin HJ; Chou CY
    BMC Nephrol; 2023 Apr; 24(1):106. PubMed ID: 37087421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time course of peritoneal function in automated and continuous peritoneal dialysis.
    Michels WM; Verduijn M; Parikova A; Boeschoten EW; Struijk DG; Dekker FW; Krediet RT
    Perit Dial Int; 2012; 32(6):605-11. PubMed ID: 22473037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison between 1.36% and 3.86% glucose dialysis solution for the assessment of peritoneal membrane function.
    Smit W; Langedijk MJ; Schouten N; van den Berg N; Struijk DG; Krediet RT
    Perit Dial Int; 2000; 20(6):734-41. PubMed ID: 11216568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluid and solute transport in CAPD patients before and after permanent loss of ultrafiltration capacity.
    Waniewski J; Sobiecka D; Debowska M; Heimbürger O; Weryński A; Lindholm B
    Int J Artif Organs; 2005 Oct; 28(10):976-86. PubMed ID: 16288435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of sodium removal in peritoneal dialysis patients treated by continuous ambulatory and automated peritoneal dialysis.
    Maharjan SRS; Davenport A
    J Nephrol; 2019 Dec; 32(6):1011-1019. PubMed ID: 31502219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Peritoneal equilibrium test with hypertonic exchange: practical application in a peritoneal dialysis program].
    Ortiz A; Marrón B; Berlanga JR; Reyero A; Gazapo R
    Nefrologia; 2001; 21(4):362-9. PubMed ID: 11816512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.